1177 related articles for article (PubMed ID: 19729656)
1. Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate.
Hait NC; Allegood J; Maceyka M; Strub GM; Harikumar KB; Singh SK; Luo C; Marmorstein R; Kordula T; Milstien S; Spiegel S
Science; 2009 Sep; 325(5945):1254-7. PubMed ID: 19729656
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic regulation of pro-inflammatory cytokine secretion by sphingosine 1-phosphate (S1P) in acute lung injury: Role of S1P lyase.
Ebenezer DL; Fu P; Suryadevara V; Zhao Y; Natarajan V
Adv Biol Regul; 2017 Jan; 63():156-166. PubMed ID: 27720306
[TBL] [Abstract][Full Text] [Related]
3. New endogenous regulators of class I histone deacetylases.
Riccio A
Sci Signal; 2010 Jan; 3(103):pe1. PubMed ID: 20051592
[TBL] [Abstract][Full Text] [Related]
4. Evidence for a link between histone deacetylation and Ca²+ homoeostasis in sphingosine-1-phosphate lyase-deficient fibroblasts.
Ihlefeld K; Claas RF; Koch A; Pfeilschifter JM; Meyer Zu Heringdorf D
Biochem J; 2012 Nov; 447(3):457-64. PubMed ID: 22908849
[TBL] [Abstract][Full Text] [Related]
5. Regulation of hypoxia-inducible factor functions in the nucleus by sphingosine-1-phosphate.
Hait NC; Maiti A; Xu P; Qi Q; Kawaguchi T; Okano M; Takabe K; Yan L; Luo C
FASEB J; 2020 Mar; 34(3):4293-4310. PubMed ID: 32017264
[TBL] [Abstract][Full Text] [Related]
6. Nuclear lipid mediators: Role of nuclear sphingolipids and sphingosine-1-phosphate signaling in epigenetic regulation of inflammation and gene expression.
Fu P; Ebenezer DL; Ha AW; Suryadevara V; Harijith A; Natarajan V
J Cell Biochem; 2018 Aug; 119(8):6337-6353. PubMed ID: 29377310
[TBL] [Abstract][Full Text] [Related]
7. The Intra-nuclear SphK2-S1P Axis Facilitates M1-to-M2 Shift of Microglia via Suppressing HDAC1-Mediated KLF4 Deacetylation.
Ji J; Wang J; Yang J; Wang XP; Huang JJ; Xue TF; Sun XL
Front Immunol; 2019; 10():1241. PubMed ID: 31214192
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanism of sphingosine-1-phosphate action in Duchenne muscular dystrophy.
Nguyen-Tran DH; Hait NC; Sperber H; Qi J; Fischer K; Ieronimakis N; Pantoja M; Hays A; Allegood J; Reyes M; Spiegel S; Ruohola-Baker H
Dis Model Mech; 2014 Jan; 7(1):41-54. PubMed ID: 24077965
[TBL] [Abstract][Full Text] [Related]
9. Statins increase p21 through inhibition of histone deacetylase activity and release of promoter-associated HDAC1/2.
Lin YC; Lin JH; Chou CW; Chang YF; Yeh SH; Chen CC
Cancer Res; 2008 Apr; 68(7):2375-83. PubMed ID: 18381445
[TBL] [Abstract][Full Text] [Related]
10. Regulation and function of sphingosine kinase 2 in diseases.
Song DD; Zhou JH; Sheng R
Histol Histopathol; 2018 May; 33(5):433-445. PubMed ID: 29057430
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formation.
Zika E; Greer SF; Zhu XS; Ting JP
Mol Cell Biol; 2003 May; 23(9):3091-102. PubMed ID: 12697811
[TBL] [Abstract][Full Text] [Related]
12. Targeting AML1/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cells.
Liu S; Klisovic RB; Vukosavljevic T; Yu J; Paschka P; Huynh L; Pang J; Neviani P; Liu Z; Blum W; Chan KK; Perrotti D; Marcucci G
J Pharmacol Exp Ther; 2007 Jun; 321(3):953-60. PubMed ID: 17389244
[TBL] [Abstract][Full Text] [Related]
13. Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2.
Alvarez SE; Harikumar KB; Hait NC; Allegood J; Strub GM; Kim EY; Maceyka M; Jiang H; Luo C; Kordula T; Milstien S; Spiegel S
Nature; 2010 Jun; 465(7301):1084-8. PubMed ID: 20577214
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic mechanisms in the dopamine D2 receptor-dependent inhibition of the prolactin gene.
Liu JC; Baker RE; Chow W; Sun CK; Elsholtz HP
Mol Endocrinol; 2005 Jul; 19(7):1904-17. PubMed ID: 15731170
[TBL] [Abstract][Full Text] [Related]
15. Endogenous modulators and pharmacological inhibitors of histone deacetylases in cancer therapy.
Spiegel S; Milstien S; Grant S
Oncogene; 2012 Feb; 31(5):537-51. PubMed ID: 21725353
[TBL] [Abstract][Full Text] [Related]
16. FOXP3 up-regulates p21 expression by site-specific inhibition of histone deacetylase 2/histone deacetylase 4 association to the locus.
Liu R; Wang L; Chen G; Katoh H; Chen C; Liu Y; Zheng P
Cancer Res; 2009 Mar; 69(6):2252-9. PubMed ID: 19276356
[TBL] [Abstract][Full Text] [Related]
17. Gfi1 coordinates epigenetic repression of p21Cip/WAF1 by recruitment of histone lysine methyltransferase G9a and histone deacetylase 1.
Duan Z; Zarebski A; Montoya-Durango D; Grimes HL; Horwitz M
Mol Cell Biol; 2005 Dec; 25(23):10338-51. PubMed ID: 16287849
[TBL] [Abstract][Full Text] [Related]
18. The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21/WAF1/CIP1 gene.
Lagger G; Doetzlhofer A; Schuettengruber B; Haidweger E; Simboeck E; Tischler J; Chiocca S; Suske G; Rotheneder H; Wintersberger E; Seiser C
Mol Cell Biol; 2003 Apr; 23(8):2669-79. PubMed ID: 12665570
[TBL] [Abstract][Full Text] [Related]
19. Elevated Nuclear and Cytoplasmic FTY720-Phosphate in Mouse Embryonic Fibroblasts Suggests the Potential for Multiple Mechanisms in FTY720-Induced Neural Tube Defects.
Gardner NM; Riley RT; Showker JL; Voss KA; Sachs AJ; Maddox JR; Gelineau-van Waes JB
Toxicol Sci; 2016 Mar; 150(1):161-8. PubMed ID: 26719367
[TBL] [Abstract][Full Text] [Related]
20. Sphingosine kinase 2 and sphingosine-1-phosphate promotes mitochondrial function in dopaminergic neurons of mouse model of Parkinson's disease and in MPP+ -treated MN9D cells in vitro.
Sivasubramanian M; Kanagaraj N; Dheen ST; Tay SS
Neuroscience; 2015 Apr; 290():636-48. PubMed ID: 25637806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
